A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-01796198
Contributor : Lauriane Pillet <>
Submitted on : Saturday, May 19, 2018 - 11:34:33 AM
Last modification on : Friday, May 24, 2019 - 10:39:50 AM

Links full text

Identifiers

Collections

Citation

H. S. Walter, S. A. Rule, M. J. S. Dyer, L. Karlin, C. Jones, et al.. A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies. Blood, American Society of Hematology, 2016, 127 (4), pp.411-419. ⟨10.1182/blood-2015-08-664086⟩. ⟨hal-01796198⟩

Share

Metrics

Record views

64